| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |